There are 2934 resources available
Checkpoint inhibitors in special populations
Presenter: Alexander Menzies
Session: Special clinical scenarios in management of advanced melanoma
Resources:
Slides
Webcast
When can we stop immunotherapy in patients with clinical benefit?
Presenter: Dirk Schadendorf
Session: Special clinical scenarios in management of advanced melanoma
Resources:
Slides
Webcast
Introduction: Where can patient care plans/national guidelines fit into NCCP?
Presenter: Jose Martin-Moreno
Session: The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care
Resources:
Slides
Webcast
The National Cancer Control Plan of Uzbekistan: Update on progress from 2015 to 2019
Presenter: Mirzagaleb Tillyashaykhov
Session: The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care
Resources:
Slides
Webcast
Russia outlook: Features of the NCCP - Work in progress
Presenter: Vsevolod Matveev
Session: The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care
Resources:
Slides
Webcast
3502 - Randomised Efficacy and Safety Results For Atezolizumab (Atezo) + Bevacizumab (Bev) in Patients (pts) With Previously Untreated, Unresectable Hepatocellular Carcinoma (HCC)
Presenter: Michael Lee
Session: Proffered Paper 1 – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
Proffered Paper 1 – Gastrointestinal tumours, non-colorectal - Invited Discussant LBA38_PR and LBA39
Presenter: Arndt Vogel
Session: Proffered Paper 1 – Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
2550 - FIGHT-202: a phase 2 study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA)
Presenter: Arndt Vogel
Session: Proffered Paper 1 – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
Proffered Paper 1 – Gastrointestinal tumours, non-colorectal - Invited Discussant 671O and LBA40
Presenter: Per Pfeiffer
Session: Proffered Paper 1 – Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Proffered Paper – Genitourinary tumours, prostate - Invited Discussant 843O and 844O
Presenter: Karim Fizazi
Session: Proffered Paper – Genitourinary tumours, prostate
Resources:
Slides
Webcast